Sharing Formulations Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 10-12-2024
- Paid Up Capital ₹ 0.10 M
as on 10-12-2024
- Company Age 7 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 8.29 M
as on 10-12-2024
- Revenue 14.29%
(FY 2020)
- Profit -563.33%
(FY 2020)
- Ebitda 87.06%
(FY 2020)
- Net Worth -208.99%
(FY 2020)
- Total Assets -2.11%
(FY 2020)
About Sharing Formulations
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹8.29 M.
Sanjaykumar Agrawal and Hiteshkumar Agrwal serve as directors at the Company.
- CIN/LLPIN
U24304GJ2017PTC097210
- Company No.
097210
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 May 2017
- Date of AGM
22 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Sharing Formulations Private Limited offer?
Sharing Formulations Private Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Antacid Drugs, Common Disease Medicines, Antiseptic Mouthwashes, Nutraceuticals & Dietary Supplements, Mineral Supplement, Skin Lightening Drugs, Hand Sanitizers & Personal Hygiene, Antiseptic Liquid & Cream, TB, Tumor & Cancer Drugs.
Who are the key members and board of directors at Sharing Formulations?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjaykumar Agrawal  | Director | 10-Apr-2018 | Current |
| Hiteshkumar Agrwal | Director | 03-May-2017 | Current |
Financial Performance of Sharing Formulations.
Sharing Formulations Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 14.29% increase. The company also saw a substantial fall in profitability, with a 563.33% decrease in profit. The company's net worth observed a substantial decline by a decrease of 208.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sharing Formulations?
In 2020, Sharing Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Yes Bank Limited Creation Date: 03 Nov 2018 | ₹8.29 M | Open |
How Many Employees Work at Sharing Formulations?
Sharing Formulations has a workforce of 9 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sharing Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sharing Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
